Phase 1, Double Blind, Randomized, Parallel-Group, Single-Dose, 3-Arm, Comparative Pharmacokinetic Study Of PF-05280014 And Trastuzumab Sourced From US And EU Administered To Healthy Male Volunteers
Phase of Trial: Phase I
Latest Information Update: 02 Jun 2015
At a glance
- Drugs Trastuzumab (Primary)
- Indications Breast cancer; Gastric cancer
- Focus Pharmacokinetics
- Sponsors Pfizer
- 02 Jun 2015 Results presented at the 51st Annual Meeting of the American Society of Clinical Oncology.
- 09 Sep 2013 Primary endpoint 'Peak-drug-concentration' has been met according to results presented at the 2013 Breast Cancer Symposium.
- 09 Sep 2013 Primary endpoint 'Area-under-the-drug-concentration-time-curve' has been met according to results presented at the 2013 Breast Cancer Symposium.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History